An In-Depth Understanding of the Chinese Pharmaceutical Industry

MUMBAI, October 1, 2013 /PRNewswire/ --

Bharat Book Bureau Presents Pharmaceutical Industry China - Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges. ( http://www.bharatbook.com/healthcare-market-research-reports/pharmaceutical-industry-china.html )

     (Logo: http://photos.prnewswire.com/prnh/20130128/590935 )

It is a comprehensive report on the pharmaceutical and biotechnology industry in China and its impact on international markets. This report tackles not only global pharmaceutical company interest in China but also home grown companies and their battle for position. The business environment in which they compete is analyzed as are key drivers, constraints, challenges and opportunities.

A wealth of financial information is provided including:

• Company financials, sales & revenue figures - historical to Q2•2013
• China GDP, economic growth, export (bulk drug, formulations) figures
• Indian health expenditure as a function of GDP
• Growth change figures of emerging and developing countries (India, Russia, China, Brazil)
• Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada)
• Projected figures of strategic emerging industry GDP percentage contribution

SWOT, Economic and Business Environment specifics include:

• Key strengths, weaknesses and threats influencing leading player position within the market
• Top Five Contract Pharmaceutical Export Markets of China
• Major players within China's leading therapeutic markets (e.g., cancer, allergy, liver disease)
• Multinational penetration into the Chinese Pharma Market
• Comprehensive product portfolios, R&D activity and pipeline therapeutics
• M&A activity and future strategies of top Chinese pharmacos
• Economic indicators, trade policy, merchandise and commercial trade statistics
• Gross Domestic Product of China, historic and projection analysis
• Chinese economic outlook in comparison to advanced economies
• Three Tier 'Pharmerging' Markets with Potential for Significant Growth
• Prescription drug sales distribution channels in China
• Major Biogeneric products in China

The Chinese biopharmaceutical market is presented as follows:

• By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS)
• By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)

What you will gain:

• An in-depth understanding of the Chinese biopharmaceutical market and it's environment
• Current market facts, figures and product lines of key players in the industry
• An insight into how generic therapeutics will propagate the Chinese biopharmaceutical market
• Knowledge of how the Chinese pharma market will integrate into the global healthcare market
•  Information on key regulatory and government policies
•  Data on levels of private and publically funded biopharma studies in China
• Strategies on how to adapt and restructure current business models to this industry

Key concerns to the Chinese biopharmaceutical market such as:

• Lack of regulatory policy and legislation
• Reimbursement schemes and payers concerns
• Funding and government sponsorship issues
• International scepticism of Chinese safety and efficacy therapeutic profiles

This report will tell you if the companies mentioned are:

• Strong, competitive players
• Pooling their resources for specific growth and therapeutic areas
• Investing strategically in R&D
• Have a history of strategic M&A activity

Covers significant Chinese and multinational pharmacos and gives details of their operations, products, financials and business strategy:

• Amoytop Biotech
• Active Pharmaceutical Products
• Beijing Continent Pharmaceuticals
• FusoGen Pharmaceuticals
• Shanghai Huaguan Biochip
• SiBiono GeneTech
• Abbott
• AstraZeneca
• Boehringer Ingelheim
• Eli Lilly
• GlaxoSmithKline
• Johnson & Johnson Medical
• Merck
• Novartis
• Pfizer
• Roche

Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=408064

For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/pharmaceutical-industry-china.html

Related Reports:

• Opportunity in Pharmaceutical Labels Market in India 2013
• Pharmaceutical Sector in India 2013
• CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK
• Bioseparation Systems for Global Biopharmaceutical Markets
  

Related Category:

• Pharmaceutical
• Biopharma
• Healthcare

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:
Poonam
Bharat Book Bureau
UK: +44 7405 208461
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Skype - bharatbook
E-mail: [email protected]
Website: http://www.bharatbook.com
Live Chat - http://bit.ly/19m3TU4

SOURCE Bharat Book Bureau

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED